Latest From Biotech Now

Achieving Food Security by 2050

“As the world population surpasses 9 billion people as estimated in 2050, increased demand for beef will be driven by the estimated 3 billion people expected to join the middle class who will be able to afford to add meat, milk and eggs to their diets,” Elanco, a global animal health company, claimed in a recent release. Agrimarketing covered Elanco’s statement on how farming innovations have allowed the beef industry to freeze carbon footprint and save Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Deal Structures: More Options for Companies

CEO2013_115x75_Thumbnail copy

By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal values, , licensing values and volume were all up, as were big pharma M&A deals and asset swaps. What do these trends mean for dealmakers in 2015? Answering that question was the task of a panel at the 2015 BIO CEO & Investor Conference, Emerging Trends in Deal Structures. Moderated by Fenwick and West’s Effie Toshav, the panel included: Bruce Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , ,

Fireside Chats with Five CEOs Featured at Day Two of the BIO CEO & Investor Conference

DSC_9222

Fireside Chat with John F. Milligan, PhD, President & COO, Gilead Sciences The first fireside chat of the BIO CEO and Investor Conference featured John F. Milligan, Ph.D. President & COO of Gilead Sciences.  In a session moderated by Barclays analyst Geoff Meacham, Dr. Milligan was optimistic that sales of Gilead’s Hepatitis C treatments would see expanded sales volumes as more providers become comfortable with the regimens and treating HCV patients, according to Milligan. He Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Kaylee_dna_115x76

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, “Trust Your Gut” – Therapeutic Opportunities from the Microbiome. The panel was moderated by Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co. The panelists were: Martin J. Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, Director, Human Microbiome Program, New York University Langone Medical Center Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome Michael Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Celebrate Valentine’s Day with Color Changing Flowers

admin-ajax.php

Wouldn’t it be great if you could break the mold and give your special someone something other than Roses for Valentine’s Day? Research being done at Revolution Bioengineering may allow you to do just that. Revolution Bioengineering is a new biotech company in Fort Collins, CO that is working on building a Petunia Circadia, a flower that changes color throughout the day. The petunia will be developed using synthetic biology. “There are exciting opportunities available right now in Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,